Mutations of DNAI1 in Primary Ciliary Dyskinesia. Mutations of DNAI1 in Primary Ciliary Dyskinesia: Evidence of Founder Effect in a Common Mutation

Archive ouverte

Zariwala, Maimoona, A | Leigh, Margaret, W | Ceppa, Franck | Kennedy, Marcus, P | Noone, Peadar, G | Carson, Johnny, L | Hazucha, Milan, J | Lori, Adriana | Horvath, Judit | Olbrich, Heike | Loges, Niki, T | Bridoux, Anne-Marie | Pennarun, Gaëlle | Duriez, Bénédicte | Escudier, Estelle | Mitchison, Hannah, M | Chodhari, Rahul | Chung, Eddie, M K | Morgan, Lucy, C | de Iongh, Robbert, U | Rutland, Jonathan | Pradal, Ugo | Omran, Heymut | Amselem, Serge | Knowles, Michael, R

Edité par CCSD ; American Thoracic Society -

International audience. Rationale: Primary ciliary dyskinesia (PCD) is a rare, usually autosomal recessive, genetic disorder characterized by ciliary dysfunction, sino-pulmonary disease, and situs inversus. Disease-causing mutations have been reported in DNAI1 and DNAH5 encoding outer dynein arm (ODA) proteins of cilia.Objectives: We analyzed DNAI1 to identify disease-causing mutations in PCD and to determine if the previously reported IVS1+2_3insT (219+3insT) mutation represents a "founder" or "hot spot" mutation.Methods: Patients with PCD from 179 unrelated families were studied. Exclusion mapping showed no linkage to DNAI1 for 13 families; the entire coding region was sequenced in a patient from the remaining 166 families. Reverse transcriptase-polymerase chain reaction (RT-PCR) was performed on nasal epithelial RNA in 14 families.Results: Mutations in DNAI1 including 12 novel mutations were identified in 16 of 179 (9%) families; 14 harbored biallelic mutations. Deep intronic splice mutations were not identified by reverse transcriptase-polymerase chain reaction. The prevalence of mutations in families with defined ODA defect was 13%; no mutations were found in patients without a defined ODA defect. The previously reported IVS1+2_3insT mutation accounted for 57% (17/30) of mutant alleles, and marker analysis indicates a common founder for this mutation. Seven mutations occurred in three exons (13, 16, and 17); taken together with previous reports, these three exons are emerging as mutation clusters harboring 29% (12/42) of mutant alleles.Conclusions: A total of 10% of patients with PCD are estimated to harbor mutations in DNAI1; most occur as a common founder IVS1+2_3insT or in exons 13, 16, and 17. This information is useful for establishing a clinical molecular genetic test for PCD.

Suggestions

Du même auteur

A Heterozygous Mutation Disrupting the SPAG16 Gene Results in Biochemical Instability of Central Apparatus Components of the Human Sperm Axoneme1

Archive ouverte | Zhang, Zhibing | CCSD

International audience. The SPAG16 gene encodes two major transcripts, one for the 71-kDa SPAG16L, which is the orthologue of the Chlamydomonas rheinhardtii central apparatus protein PF20, and a smaller transcript, ...

A Heterozygous Mutation Disrupting the SPAG16 Gene Results in Biochemical Instability of Central Apparatus Components of the Human Sperm Axoneme1

Archive ouverte | Zhang, Zhibing | CCSD

International audience. The SPAG16 gene encodes two major transcripts, one for the 71-kDa SPAG16L, which is the orthologue of the Chlamydomonas rheinhardtii central apparatus protein PF20, and a smaller transcript, ...

Lack of GAS2L2 Causes PCD by Impairing Cilia Orientation and Mucociliary Clearance

Archive ouverte | Bustamante-Marin, Ximena | CCSD

International audience

Chargement des enrichissements...